Last reviewed · How we verify

NCT05252208

Stretching vs Walking for Lowering Blood Pressure

Recruiting now NA Last updated 23 April 2025
What this trial tests

NA trial testing Stretching exercise in Hypertension in 96 participants. Currently enrolling.

Timeline
28 March 2022
Primary endpoint
28 February 2026
30 August 2026

Quick facts

Lead sponsorUniversity of Saskatchewan
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment96
Start date28 March 2022
Primary completion28 February 2026
Estimated completion30 August 2026
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Saskatchewan

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High blood pressure is a leading risk factor for cardiovascular disease. Traditionally, one of the ways to treat or prevent high blood pressure is to prescribe aerobic exercise training (i.e. brisk walking). Stretching may also be effective because it may cause changes in blood vessel stiffness and therefore reduce resistance to blood flow. The study will assess a group of individuals (i.e. 96) participating in a supervised stretching or walking program five days per week for six months to determine whether stretching is superior for reducing blood pressure. This research will contribute to recommendations about the most effective exercise programs for reducing blood pressure and risk of cardiovascular disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Stretching exercise

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other University of Saskatchewan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05252208.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing